Turudic, D.; Milosevic, D.; Bilic, K.; Prohászka, Z.; Bilic, E.
A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review. J. Clin. Med. 2022, 11, 2779.
https://doi.org/10.3390/jcm11102779
AMA Style
Turudic D, Milosevic D, Bilic K, Prohászka Z, Bilic E.
A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review. Journal of Clinical Medicine. 2022; 11(10):2779.
https://doi.org/10.3390/jcm11102779
Chicago/Turabian Style
Turudic, Daniel, Danko Milosevic, Katarina Bilic, Zoltán Prohászka, and Ernest Bilic.
2022. "A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review" Journal of Clinical Medicine 11, no. 10: 2779.
https://doi.org/10.3390/jcm11102779
APA Style
Turudic, D., Milosevic, D., Bilic, K., Prohászka, Z., & Bilic, E.
(2022). A Limited Course of Eculizumab in a Child with the Atypical Hemolytic Uremic Syndrome and Pre-B Acute Lymphoblastic Leukemia on Maintenance Therapy: Case Report and Literature Review. Journal of Clinical Medicine, 11(10), 2779.
https://doi.org/10.3390/jcm11102779
